Light Therapy Aids Psychobehavioral Symptoms With Alzheimer Disease
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 8, 2023 -- Light therapy is associated with significant improvement in sleep and psychobehavioral symptoms in patients with Alzheimer disease, according to a review published online Dec. 6 in PLOS ONE.
Lili Zang, from Weifang Medical University in China, and colleagues conducted a systematic literature review to identify studies evaluating the efficacy of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer disease.
Based on 15 included randomized controlled trials (including 598 participants with Alzheimer disease), the researchers found that light therapy significantly improved sleep efficiency (mean difference [MD], −2.42), increased interdaily stability (MD, −0.04), and reduced intradaily variability (MD, −0.07). There were also significant benefits with light therapy for alleviating depression (MD, −2.55) and reducing agitation (MD, −3.97) and caregiver burden (MD, −3.57).
"These findings combined with its low side effects suggest the role of light therapy as a promising treatment for Alzheimer disease. Although light therapy has fewer side effects than pharmacological treatment, adverse behavioral outcomes in patients due to bright light exposure should be considered," the authors write. "Nevertheless, further studies with appropriately larger sample sizes are necessitated to elucidate the effectiveness of light therapy in treating sleep disorders and psychobehavioral symptoms in patients with Alzheimer disease."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Lower Cognitive Function in Adolescence Linked to Stroke Risk
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.